Disease Information for Circulating coagulation inhibitor

Ads
Demographics & Risk Factors
Established Disease Population
Patient/Lupus erythematosis, systemic
Patient/Coagulopathy
Laboratory Tests
Abnormal Lab Findings (Non Measured)
Bethesda titer/Clotting inhibitor abnormal (Lab)
Clotting Mixing studies/Inhibitors abnormal (Lab)
Coagulation/Clotting factors decreased (Lab)
PTT increased normal PT (Lab)
Abnormal Lab Findings - Increased
Anti-factor IX inhibitor (Lab)
Anti-factor VIII inhibitor (Lab)
Addition Clotting Correction Fails (Lab)
Clotting time/Activated clotting time test (Lab)
PTT/Partial Thromboplastin Time/Activated PTT (Lab)
Associated Diseases & Rule outs
Associated Disease & Complications
Bleeding complications/Surgery
Bleeding diathesis/hemorrhagic diathesis
Bleeding Tendency
Circulating coagulation inhibitor status
Disease Mechanism & Classification
Class
CLASS/Hematologic (category)
Process
PROCESS/Allergy/collagen/autoimmune (category)
PROCESS/Autoimmune disorder (ex)
PROCESS/Coagulation derangement/disorder (ex)
Treatment
Drug Therapy - Indication
RX/Alkylating agents
RX/Cyclophosphamide (Cytoxan)
RX/Immune-suppression
RX/Prednisone (Deltasone)
RX/Vincristine (Oncovin)
Other Treatments
TX/Plasmapheresis/exchange.
Definition
Be the first to add a definition for Circulating coagulation inhibitor
External Links Related to Circulating coagulation inhibitor
Google
Wikipedia
Merck
Images
PubMed (National Library of Medicine)
NGC (National Guideline Clearinghouse)
Medscape (eMedicine)
Harrison's Online (accessmedicine)
NEJM (The New England Journal of Medicine)
Ads